Medulloblastoma: optimizing care with a multidisciplinary approach

References

• TaillandierLBlonskiMCarrieCLes médulloblastomes: revue générale [Medulloblastomas: review]Rev Neurol2011167543144821529869
   PubMed Web of Science ®Google Scholar
• OstromQTGittlemanHLiaoPCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011Neuro Oncol201416suppl 4iv1iv6325304271
   PubMed Web of Science ®Google Scholar
• JohnsonKJCullenJBarnholtz-SloanJSChildhood brain tumor epidemiology: a Brain Tumor Epidemiology Consortium ReviewCanc Epidemiol Biomarkers Prev2014231227162736
   PubMed Web of Science ®Google Scholar
• FellayCNFrappazDSunyachMPFranceschiEBrandesAAStuppRMedulloblastomas in adults: prognostic factors and lessons from paediatricsCurr Opin Neurol201124662663222027544
   PubMed Web of Science ®Google Scholar
• RamaswamyVRemkeMBouffetERisk stratification of childhood medulloblastoma in the molecular era: the current consensusActa Neuropathol2016131682183127040285
   PubMed Web of Science ®Google Scholar
• RamaswamyVRemkeMAdamskiJMedulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?Neuro Oncol201618229129725605817
   PubMed Web of Science ®Google Scholar
• TarbellNJFriedmanHPolkinghornWRHigh-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)J Clin Oncol201331232936294123857975
   PubMed Web of Science ®Google Scholar
• Moxon-EmreIBouffetETaylorMDImpact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastomaJ Clin Oncol201432171760176824516024
   PubMed Web of Science ®Google Scholar
• Moxon-EmreITaylorMDBouffetEIntellectual outcome in molecular subgroups of medulloblastomaJ Clin Oncol201634344161417027507873
   PubMed Web of Science ®Google Scholar
• FossatiPRicardiUOrecchiaRPediatric medulloblastoma: toxicity of current treatment and potential role of protontherapyCancer Treat Rev2009351799618976866
   PubMed Web of Science ®Google Scholar
• EllisonDWOniludeOELindseyJCBeta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour CommitteeJ Clin Oncol200523317951795716258095
   PubMed Web of Science ®Google Scholar
• HermsJNeidtILüscherBC-MYC expression in medulloblastoma and its prognostic valueInt. J. Cancer200089539540211008200
   PubMed Web of Science ®Google Scholar
• LouisDNPerryAReifenbergerGThe 2016 World Health Organization classification of tumors of the central nervous system: a summaryActa Neuropathol2016131680382027157931
   PubMed Web of Science ®Google Scholar
• EllisonDWDaltonJKocakMMedulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsActa Neuropathol2011121338139621267586
   PubMed Web of Science ®Google Scholar
• EllisonDWChildhood medulloblastoma: novel approaches to the classification of a heterogeneous diseaseActa Neuropathol2010120330531620652577
   PubMed Web of Science ®Google Scholar
• GiangasperoFRigobelloLBadialiMLarge-cell medulloblastomas. A distinct variant with highly aggressive behaviorAm J Surg Pathol19921676876931530108
   PubMed Web of Science ®Google Scholar
• LouisDNOhgakiHWiestlerODThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol200711429710917618441
   PubMed Web of Science ®Google Scholar
• ZeltzerPMBoyettJMFinlayJLMetastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III studyJ Clin Oncol199917383284510071274
   PubMed Web of Science ®Google Scholar
• ChangCHHousepianEMHerbertCAn operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomasRadiology1969936135113594983156
   PubMed Web of Science ®Google Scholar
• MartinAMRaabeEEberhartCCohenKJManagement of pediatric and adult patients with medulloblastomaCurr Treat Options in Oncol2014154581594
   PubMed Web of Science ®Google Scholar
• LanneringBRutkowskiSDozFHyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trialJ Clin Oncol201230263187319322851561
   PubMed Web of Science ®Google Scholar
• PackerRJGajjarAVezinaGPhase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastomaJ Clin Oncol200624254202420816943538
   PubMed Web of Science ®Google Scholar
• PomeroySLTamayoPGaasenbeekMPrediction of central nervous system embryonal tumour outcome based on gene expressionNature2002415687043644211807556
   PubMed Web of Science ®Google Scholar
• ThompsonMCFullerCHoggTLGenomics identifies medulloblastoma subgroups that are enriched for specific genetic alterationsJ Clin Oncol200624121924193116567768
   PubMed Web of Science ®Google Scholar
• KoolMKosterJBuntJIntegrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresPLoS One200838e308818769486
   PubMed Web of Science ®Google Scholar
• ChoY-JTsherniakATamayoPIntegrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeJ Clin Oncol201129111424143021098324
   PubMed Web of Science ®Google Scholar
• NorthcottPAKorshunovAWittHMedulloblastoma comprises four distinct molecular variantsJ Clin Oncol201129111408141420823417
   PubMed Web of Science ®Google Scholar
• TaylorMDNorthcottPAKorshunovAMolecular subgroups of medulloblastoma: the current consensusActa Neuropathologica2012123446547222134537
   PubMed Web of Science ®Google Scholar
• KoolMKorshunovARemkeMMolecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomasActa Neuropathol2012123447348422358457
   PubMed Web of Science ®Google Scholar
• CliffordSCLanneringBSchwalbeECBiomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: results from the multi-center HIT-SIOP-PNET4 clinical trialOncotarget2015636388273883926420814
   PubMed Web of Science ®Google Scholar
• PietschTSchmidtRRemkeMPrognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortActa Neuropathol2014128113714924791927
   PubMed Web of Science ®Google Scholar
• NorthcottPAJonesDTWKoolMMedulloblastomics: the end of the beginningNat Rev Cancer2012121281883423175120
   PubMed Web of Science ®Google Scholar
• RobinsonGParkerMKranenburgTANovel mutations target distinct subgroups of medulloblastomaNature20124887409434822722829
   PubMed Web of Science ®Google Scholar
• HamiltonSRLiuBParsonsREThe molecular basis of Turcot’s syndromeN Engl J Med1995332138398477661930
   PubMed Web of Science ®Google Scholar
• TrubickaJSzperlMGrajkowskaWIdentification of a novel inherited ALK variant M1199L in the WNT type of medulloblastomaFolia Neuropathol2016112330
   Web of Science ®Google Scholar
• NorthcottPAKorshunovAPfisterSMTaylorMDThe clinical implications of medulloblastoma subgroupsNat Rev Neurol20128634035122565209
   PubMed Web of Science ®Google Scholar
• EllisonDWKocakMDaltonJDefinition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesJ Clin Oncol201129111400140720921458
   PubMed Web of Science ®Google Scholar
• GibsonPTongYRobinsonGSubtypes of medulloblastoma have distinct developmental originsNature201046873271095109921150899
   PubMed Web of Science ®Google Scholar
• TaylorMDLiuLRaffelCMutations in Sufu predispose to medulloblastomaNat Genet200231330631012068298
   PubMed Web of Science ®Google Scholar
• O’MalleySWeitmanDOldingMSekharLMultiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case reportJ Neurosurg19978622862889010431
   PubMed Web of Science ®Google Scholar
• RamaswamyVTaylorMDMedulloblastoma: from myth to molecularJCO2017352123552363
   PubMed Web of Science ®Google Scholar
• ZhukovaNRamaswamyVRemkeMSubgroup-specific prognostic implications of TP53 mutation in medulloblastomaJ Clin Oncol201331232927293523835706
   PubMed Web of Science ®Google Scholar
• WilliamsJRZhangYZhouHA quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 statusInt J Radiat Biol200884425326418386191
   PubMed Web of Science ®Google Scholar
• TchelebiLAshamallaHGravesPRMutant p53 and the response to chemotherapy and radiationSubcell Biochem20148513315925201193
   PubMedGoogle Scholar
• KoolMJonesDTWJägerNGenome sequencing of Shh medulloblastoma predicts genotype-related response to smoothened inhibitionCancer Cell201425339340524651015
   PubMed Web of Science ®Google Scholar
• ColucciaDFiguereidoCIsikSSmithCRutkaJTMedulloblastoma: tumor biology and relevance to treatment and prognosis paradigmCurr Neurol Neurosci Rep20161654327021772
   PubMed Web of Science ®Google Scholar
• HuangG-HXuQ-FCuiY-HLiNBianX-WLvS-QMedulloblastoma stem cells: promising targets in medulloblastoma therapyCancer Sci2016107558358927171351
   PubMed Web of Science ®Google Scholar
• NorthcottPALeeCZichnerTEnhancer hijacking activates Gfi1 family oncogenes in medulloblastomaNature2014511751042843425043047
   PubMed Web of Science ®Google Scholar
• ShihDJHNorthcottPARemkeMCytogenetic prognostication within medulloblastoma subgroupsJ Clin Oncol201432988689624493713
   PubMed Web of Science ®Google Scholar
• ZhouLPicardDRaY-SSilencing of thrombospondin-1 is critical for Myc-induced metastatic phenotypes in medulloblastomaCancer Res201070208199821020876797
   PubMed Web of Science ®Google Scholar
• RamaswamyVRemkeMBouffetERecurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisLancet Oncol201314121200120724140199
   PubMed Web of Science ®Google Scholar
• ArcherTCMahoneyELPomeroySLMedulloblastoma: molecular classification-based personal therapeuticsNeurotherapeutics201714226527328386677
   PubMed Web of Science ®Google Scholar
• RamaswamyVRemkeMShihDDuration of the pre-diagnostic interval in medulloblastoma is subgroup dependentPediatr Blood Cancer20146171190119424616042
   PubMed Web of Science ®Google Scholar
• Miranda Kuzan-FischerCJuraschkaKTaylorMDMedulloblastoma in the molecular eraJ Korean Neurosurg Soc201861329230129742881
   PubMed Web of Science ®Google Scholar
• GuSChenKYinMWuZWuYProteomic profiling of isogenic primary and metastatic medulloblastoma cell lines reveals differential expression of key metastatic factorsJ Proteomics2017160556328363815
   PubMed Web of Science ®Google Scholar
• CavalliFMGRemkeMRampasekLIntertumoral heterogeneity within medulloblastoma subgroupsCancer Cell201731673775428609654
   PubMed Web of Science ®Google Scholar
• NorthcottPABuchhalterIMorrissyASThe whole-genome landscape of medulloblastoma subtypesNature2017547766331131728726821
   PubMed Web of Science ®Google Scholar
• SchwalbeECLindseyJCNakjangSNovel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort studyLancet Oncol201718795897128545823
   PubMed Web of Science ®Google Scholar
• KortmannR-DKühlJTimmermannBPostoperative neo-adjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT’91Int J Radiat Oncol Biol Phys200046226927910661332
   PubMed Web of Science ®Google Scholar
• ChinALModingEJDonaldsonSSSurvival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastomaNeuro Oncol20182081133114129309676
   PubMed Web of Science ®Google Scholar
• PackerRJGoldweinJNicholsonHSTreatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children’s cancer group studyJ Clin Oncol19991772127213610561268
   PubMed Web of Science ®Google Scholar
• MerchantTEKunLEKrasinMJMulti-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblas-tomaInt J Radiat Oncol Biol Phys200870378278717892918
   PubMed Web of Science ®Google Scholar
• WahbaHAAbu-HegazyMWaselYIsmailEIZidanASAdjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up studyJ BUON201318242542923818356
   PubMed Web of Science ®Google Scholar
• GajjarAChintagumpalaMAshleyDRisk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (ST Jude Medul-loblastoma-96): long-term results from a prospective, multicentre trialLancet Oncol200671081382017012043
   PubMed Web of Science ®Google Scholar
• von HoffKHinkesBGerberNULong-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT’91Eur J Cancer20094571209121719250820
   PubMed Web of Science ®Google Scholar
• PackerRJSuttonLNGoldweinJWImproved survival with the use of adjuvant chemotherapy in the treatment of medulloblastomaJ Neurosurg1991133433440
   Web of Science ®Google Scholar
• Lafay-CousinLSmithAChiSNClinical, pathological, and molecular characterization of infant medulloblastomas treated with sequential high-dose chemotherapyPediatr Blood Cancer20166391527153427145464
   PubMed Web of Science ®Google Scholar
• BrandesAAErmaniMAmistaPThe treatment of adults with medulloblastoma: a prospective studyInt J Radiat Oncol Biol Phys200357375576114529781
   PubMed Web of Science ®Google Scholar
• PackerRJRoodBRMacdonaldTJMedulloblastoma: present concepts of stratification into risk groupsPediatr Neurosurg2003392606712845195
   PubMed Web of Science ®Google Scholar
• von BuerenAOKortmannR-Dvon HoffKTreatment of children and adolescents with metastatic medulloblastoma and prognostic relevance of clinical and biologic parametersJ Clin Oncol201634344151416027863192
   PubMed Web of Science ®Google Scholar
• AllenJDonahueBMehtaMA phase II study of Preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children’s Oncology Group (CCG 9931)Int J Radiat Oncol Biol Phys20097441006101119356859
   PubMed Web of Science ®Google Scholar
• von BuerenAOFriedrichCvon HoffKMetastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocolEur J Cancer201551162434244326254812
   PubMed Web of Science ®Google Scholar
• CefaloGMassiminoMRuggieroATemozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trialNeuro-Oncology201416574875324482446
   PubMed Web of Science ®Google Scholar
• KirkEAHowardVCScottCADescription of posterior fossa syndrome in children after posterior fossa brain tumor surgeryJ Pediatr Oncol Nurs19951241811877495523
   PubMedGoogle Scholar
• RobertsonPLMuraszkoKMHolmesEJIncidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children’s Oncology GroupJ Neurosurg2006105644445117184075
   PubMed Web of Science ®Google Scholar
• CeC-Bvan DongenHRMulderPGPazYGeuzeDPaquierPFLequinMHTumour type and size are high risk factors for the syndrome of “cerebellar” mutism and subsequent dysarthriaJ Neurol Neurosurg Psychiatry199967675575710567492
   PubMed Web of Science ®Google Scholar
• AlbrightALSpostoRHolmesECorrelation of neurosurgical subspecialization with outcomes in children with malignant brain tumorsNeurosurgery2000474879887 discussion 885–88711014428
   PubMed Web of Science ®Google Scholar
• Douglas CochraneDGustavssonBPoskittKPSteinbokPKestleJRWThe surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhoodPediatr Neurosurg199420119298142278
   PubMed Web of Science ®Google Scholar
• Gelabert-GonzálezMFernández-VillaJMutism after posterior fossa surgery. Review of the literatureClin Neurol Neurosurg2001103211111411516555
   PubMed Web of Science ®Google Scholar
• GrollAHRitterJMüllerFMGuidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancerKlin Padiatr2001213Suppl 1A38A4911577363
   PubMed Web of Science ®Google Scholar
• NegliaJPRobisonLLStovallMNew primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyJ Natl Cancer Inst200698211528153717077355
   PubMedGoogle Scholar
• PackerRJZhouTHolmesEVezinaGGajjarASurvival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of children’s Oncology Group trial A9961Neurooncology201315197103
   PubMed Web of Science ®Google Scholar
• KotechaRSPascoeEMRushingEJMeningiomas in children and adolescents: a meta-analysis of individual patient dataLancet Oncol201112131229123922094004
   PubMed Web of Science ®Google Scholar
• BansalLRBelairJCummingsDZuccoliGLate-onset radiation-induced vasculopathy and stroke in a child with medulloblastomaJ Child Neurol201530680080225015672
   PubMed Web of Science ®Google Scholar
• Lavoie SmithEMLiLChiangCPatterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemiaJ Peripher Nerv Syst2015201374625977177
   PubMed Web of Science ®Google Scholar
• GómezSGarrido-GarciaAGarcia-GeriqueLA novel method for rapid molecular subgrouping of medulloblastomaClin Cancer Res20182461355136329351917
   PubMed Web of Science ®Google Scholar
• CapperDJonesDTWSillMDNA methylation-based classification of central nervous system tumoursNature2018555769746947429539639
   PubMed Web of Science ®Google Scholar
• PhoenixTNPatmoreDMBoopSMedulloblastoma genotype dictates blood brain barrier phenotypeCancer Cell201629450852227050100
   PubMed Web of Science ®Google Scholar
• ManolagasSCWNT signaling and osteoporosisMaturitas201478323323724815296
   PubMed Web of Science ®Google Scholar
• RobinsonGWOrrBAWuGVismodegib exerts targeted efficacy against recurrent sonic hedgehog–subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032J Clin Oncol201533242646265426169613
   PubMed Web of Science ®Google Scholar
• NorthcottPAHielscherTDubucAPediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinctActa Neuropathol2011122223124021681522
   PubMed Web of Science ®Google Scholar
• WuS-YChiangC-MThe double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulationJ Biol Chem200728218131411314517329240
   PubMed Web of Science ®Google Scholar
• TangYGholaminSSchubertSEpigenetic targeting of hedgehog pathway transcriptional output through BET bromodomain inhibitionNat Med201420773274024973920
   PubMed Web of Science ®Google Scholar
• LongJLiBRodriguez-BlancoJThe BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancersJ Biol Chem201428951354943550225355313
   PubMed Web of Science ®Google Scholar
• FariaCCGolbournBJDubucAMForetinib is effective therapy for metastatic sonic hedgehog medulloblastomaCancer Res201575113414625391241
   PubMed Web of Science ®Google Scholar
• HanafordARArcherTCPriceADiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targetsClin Cancer Res201622153903391427012813
   PubMed Web of Science ®Google Scholar
• PeiYLiuK-WWangJHDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastomaCancer Cell201629331132326977882
   PubMed Web of Science ®Google Scholar
• VenkataramanSAlimovaIBalakrishnanIInhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastomaOncotarget2014592355237124796395
   PubMed Web of Science ®Google Scholar
• BandopadhayayPBergtholdGNguyenBBET bromodomain inhibition of MYC-amplified medulloblastomaClin Cancer Res201420491292524297863
   PubMed Web of Science ®Google Scholar
• NorthcottPAShihDJHPeacockJSubgroup-specific structural variation across 1,000 medulloblastoma genomesNature20124887409495622832581
   PubMed Web of Science ®Google Scholar
• ThompsonEMBramallAHerndonJETaylorMDRamaswamyVThe clinical importance of medulloblastoma extent of resection: a systematic reviewJ Neurooncol2018139352353929796724
   PubMed Web of Science ®Google Scholar
• ThompsonEMHielscherTBouffetEPrognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisLancet Oncol201617448449526976201
   PubMed Web of Science ®Google Scholar
• PatersonEFarrRFCerebellar medulloblastoma: treatment by irradiation of the whole central nervous systemActa radiol195339432333613057640
   PubMed Web of Science ®Google Scholar
• ThariatJHannoun-LeviJ-MSun MyintAVuongTGérardJ-PPastGJ-PPast, present, and future of radiotherapy for the benefit of patientsNat Rev Clin Oncol2013101526023183635
   PubMed Web of Science ®Google Scholar
• MichalskiJMJanssAVezinaGResults of cog ACNS0331: a phase III trial of involved-field radiotherapy (IFRT) and low dose craniospinal irradiation (LD-CSI) with chemotherapy in average-risk medulloblastoma: a report from the Children’s Oncology GroupInt J Radiation Oncol Biol Physics2016965937938
   Web of Science ®Google Scholar
• HallEJWuuC-SRadiation-induced second cancers: the impact of 3D-CRT and IMRTInt J Radiation Oncol Biol Physics20035618388
   Web of Science ®Google Scholar
• ArmstrongGTJainNLiuWRegion-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignanciesNeurooncology2010121111731186
   PubMed Web of Science ®Google Scholar
• JalaliRMallickIDuttaDFactors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapyInt J Radiat Oncol Biol Phys201077497497919864079
   PubMed Web of Science ®Google Scholar
• PadovaniLChaponFAndréNHippocampal sparing during craniospinal irradiation: what did we learn about the incidence of perihippocampus metastases?Int J Radiation Oncol Biol Physics20181004980986
   Web of Science ®Google Scholar
• LadraMMMacDonaldSMTerezakisSAProton therapy for central nervous system tumors in childrenPediatr Blood Cancer2018657e2704629630784
   PubMed Web of Science ®Google Scholar
• KamranSCGoldbergSIKuhlthauKAQuality of life in patients with proton-treated pediatric medulloblastoma: results of a prospective assessment with 5-year follow-upCancer2018124163390340029905942
   PubMed Web of Science ®Google Scholar
• HoESQBarrettSAMullaneyLMA review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastomaActa Oncol20175681031104228509599
   PubMed Web of Science ®Google Scholar
• ShenCJHuCLadraMMNarangAKCePTerezakisSASocioeconomic factors affect the selection of proton radiation therapy for children: proton therapy and socioeconomic factorsCancer2017123204048405628654202
   PubMed Web of Science ®Google Scholar
• HashimotoYPenas-PradoMZhouSRethinking medulloblastoma from a targeted therapeutics perspectiveJ Neurooncol2018139371372029869738
   PubMed Web of Science ®Google Scholar